Collectively, these results indicate that PGRN exerts protective effects against podocyte injury through autophagy restoration and CAMKK/AMPK pathway activation, potentially representing a novel therapeutic approach for diabetes mellitus (Figure 10). This evidence concerns the gene GRN and diabetes mellitus.